Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-02-14

FDA Approved: LITHIUM CARBONATE ER — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's original ANDA for extended-release lithium carbonate (lithium carbonate ER), a generic form of the mood stabilizer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium carbonate ER (Lithium carbonate)

Snippet

ORIG AP for LITHIUM CARBONATE ER (LITHIUM CARBONATE)